Evaluation of the Atlas Genetics io® CTNG System

Completed

Conditions studied: Chlamydia Trachomatis, Gonorrhea

In brief

Atlas Genetics io® system results are compared with those obtained from comparator devices.

Key facts

Study ID

NCT03071510

Run by

Binx Health Limited

People needed

7128

Starts

2017-05-18

Expected to finish

2019-08-30

Last updated by the study team

2020-04-03

Who can join

Age: 14 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Symptomatic and asymptomatic individuals ≥14 years of age

You may not qualify if…

• Treatment with antibiotics known to be effective against Chlamydia trachomatis and/or Neisseria gonorrhoeae within the previous 4 weeks before inclusion in the study.
• Unable to self-obtain a vaginal swab or urine sample of at least 30 mL

Where it is running

• University of Alabama — Birmingham, Alabama, United States
• AIDS Healthcare Foundation — Los Angeles, California, United States
• Indiana University — Indianapolis, Indiana, United States
• Louisiana State University — New Orleans, Louisiana, United States
• Johns Hopkins University — Baltimore, Maryland, United States
• University of Mississippi — Jackson, Mississippi, United States
• University of North Carolina at Chapel Hill — Chapel Hill, North Carolina, United States
• Wake Forest Center for Reproductive Medicine — Greensboro, North Carolina, United States
• Planned Parenthood Southeastern Pennsylvania — Philadelphia, Pennsylvania, United States
• Planned Parenthood Gulf Coast — Houston, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.